The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer.
Abstract
PURPOSE: We assessed the prognostic importance of the level of thymidylate synthase (TS) expression in patients with primary rectal cancer and whether, for Dukes' B and C cancer patients, the benefit of chemotherapy was associated with TS expression. PATIENTS AND METHODS: The level of TS expression in the primary rectal cancers of 294 of 801 patients enrolled on protocol R-01 of the National Surgical Adjuvant Breast and Bowel Project (NSABP) was immunohistochemically assessed with the monoclonal antibody TS 106. RESULTS: Forty-nine percent of patients whose tumors had low TS levels (n = 91) were disease free at 5 years compared with 27% of patients with high levels of TS (n = 203; P < .01). Moreover, 60% of patients with low TS levels were alive after 5 years compared with 40% of patients with high TS levels (P < .01). The level of TS protein was significantly associated with Dukes' stage (P < .01); patients with a more advanced Dukes' stage had a significantly higher level of TS. The level of TS expression remained prognostic for both disease-free survival (P < .01) and survival (P < .05) independent of Dukes' stage and other pathologic characteristics evaluated. Thirty-eight percent and 54% of patients with high TS levels (n = 71) were disease free and alive, respectively, after 5 years when treated with chemotherapy, compared with 17% and 31%, respectively, of similar patients when treated with surgery alone (n = 64) (P < .01). No difference was noted in disease-free survival (P = .46) or survival (P = .43) in patients with low TS levels. CONCLUSION: The expression of TS is an important independent prognosticator of disease-free survival and survival in patients with rectal cancer. Adjuvant fluorouracil (5-FU)-based chemotherapy demonstrated significant improvement in disease-free and overall survival for patients with high TS levels. Prospective studies measuring TS levels will be needed to understand further the role of TS as a prognosticator of survival and chemotherapeutic benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Asymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
Maximum utilization of the life table method in analyzing survival
Cutler, S. J., & Ederer, F. (1958) · Journal of Chronic Diseases · doi:10.1016/0021-9681(58)90126-7 · Cited by 2,870
Hsu, S.-M., Raine, L., & Fanger, H. (1981) · American Journal of Clinical Pathology · doi:10.1093/ajcp/75.5.734 · Cited by 1,644
THE PROGNOSTIC SIGNIFICANCE OF DIRECT EXTENSION OF CARCINOMA OF THE COLON AND RECTUM
Astler, V. B., & Coller, F. A. (1954) · Annals of Surgery · doi:10.1097/00000658-195406000-00015 · Cited by 1,104
Fisher, B., Wolmark, N., Rockette, H., Redmond, C., Deutsch, M., Wickerham, D. L., Fisher, E. R., Caplan, R., Jones, J., Lerner, H., et al. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.1.21 · Cited by 1,030
Self-citationThe Spread of Rectal Cancer and its Effect on Prognosis
Dukes, C. E., & Bussey, H. J. R. (1958) · British Journal of Cancer · doi:10.1038/bjc.1958.37 · Cited by 802
Preoperative Carcinoembryonic Antigen Level as a Prognostic Indicator in Colorectal Cancer
Wanebo, H. J., Rao, B., Pinsky, C. M., Hoffman, R. G., Stearns, M., Schwartz, M. K., & Oettgen, H. F. (1978) · New England Journal of Medicine · doi:10.1056/nejm197808312990904 · Cited by 468
Spears, C. P., Shahinian, A. H., Moran, R. G., Heidelberger, C., & Corbett, T. H. (1982) · PubMed · Cited by 273
Johnston, P. G., Drake, J. C., Trepel, J. B., & Allegra, C. J. (1992) · PubMed · Cited by 226
Self-citationPrognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma
Sun, X.-F., Carstensen, J. M., Stål, O., Wingren, S., Hatschek, T., Nordenskjöld, B., & Zhang, H. (1992) · The Lancet · doi:10.1016/0140-6736(92)92558-w · Cited by 223
Expression of p21ras in fresh primary and metastatic human colorectal tumors.
Gallick, G. E., Kurzrock, R., Kloetzer, W. S., Arlinghaus, R. B., & Gutterman, J. U. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.6.1795 · Cited by 179
c-myc oncogene expression in colorectal cancer
Sikora, K., Chan, S. Y. T., Evan, G. I., Gabra, H., Markham, N. I., Stewart, J. E., & Watson, J. (1987) · Cancer · Cited by 179
Chu, E., & Allegra, C. J. (1993) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-2488-5_16 · Cited by 166
Self-citationJohnston, P. G., Liang, C., Henry, S., Chabner, B. A., & Allegra, C. J. (1991) · PubMed · Cited by 119
Self-citationIdentification of a thymidylate synthase ribonucleoprotein complex in human colon cancer cells
Chu, E., Voeller, D. M., Jones, K. L., Takechi, T., Maley, G. F., Maley, F., Segal, S., & Allegra, C. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.207 · Cited by 83
Self-citation
Cited by
Prognostic Factors in Prostate Cancer: College of American Pathologists Consensus Statement 1999
Bostwick, D. G., Grignon, D. J., Hammond, M. E. H., Amin, M. B., Cohen, M., Crawford, D., Gospadarowicz, M., Kaplan, R. S., Miller, D. S., Montironi, R., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0995-pfipc · Cited by 1,239
Prognostic Factors in Colorectal Cancer: College of American Pathologists Consensus Statement 1999
Compton, C. C., Fielding, L. P., Burgart, L. J., Conley, B., Cooper, H. S., Hamilton, S. R., Hammond, M. E. H., Henson, D. E., Hutter, R. V. P., Nagle, R. B., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0979-pficc · Cited by 1,230
Sturgeon, C. M., Duffy, M. J., Stenman, U.-H., Lilja, H., Brünner, N., Chan, D. W., Babaian, R., Bast, R. C., Dowell, B., Esteva, F. J., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.105601 · Cited by 1,129
American Joint Committee on Cancer prognostic factors consensus conference: Colorectal working group
Compton, C., Fenoglio-Preiser, C. M., Pettigrew, N., & Fielding, L. P. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000401)88:7<1739::aid-cncr30>3.0.co;2-t · Cited by 599
Mamounas, E., Wieand, S., Wolmark, N., Bear, H. D., Atkins, J. N., Song, K., Jones, J., & Rockette, H. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1349 · Cited by 531
Self-citation
Metadata
- Authors
- Johnston, P. G., Fisher, E. R., Rockette, H. E., Fisher, B., Wolmark, N., Drake, J. C., Chabner, B. A., & Allegra, C. J.
- Venue
- Journal of Clinical Oncology
- Published
- 1994-12
- Volume
- 12
- Issue
- 12
- Pages
- 2640-2647
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1884213330
- Cited by
- 405
- References
- 17
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.